cheaper in India compared to developed countries. Global pharmaceutical companies are contracting their projects with Indian companies for several reasons: increasing profit, cost-reduction process of drug development…
pharmaceutical processes. Moisture might increase the mobility of the drug, thereby increasing the chances of recrystallization. Some other draw backs include not being able to scale up the process satisfactorily…
were died and about 200 were fill ill in 2005. A large number of pharmaceutical drugs in highly alarming amount were found in different components of drinking water (surface water ... drugs. The analytical method…
angiogenesis process. Arginine improved also the biological effects of the polymeric matrix based on chitosan-hyaluronic acid-bentonite. Conclusion & Significance: The features and biological effects of the developed…
search for new molecules with therapeutic activity is a laborious process with an elevated economic cost. To find a new therapeutic activity for a compound which is provided with pharmacological ... toxicological…
active, disease state marker) with ethanol as vehicle. Using these excipients and manipulating EHDA process parameters, led to deposition of particles (100 nm to 3um) and fibres ... Microneedle arrays as transdermal and…
drug loaded polymeric fibers containing PEs. EHDA is an on-demand; simple, easily amendable process (figure 1) capable of producing uniform structures which can be utilised as coatings for ocular ... electrospinning to…
European Medicines Agency (EMA), and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), have implemented regulatory pathways to expedite drug development, review, and approval for promising new therapies…
also after drug approval in post-marketing phase. Pharmaceutical companies accumulate the data throughout the discovery and development process in order to get approval for release a drug
processing of materials and machines. While most pharmaceutical industries from the industrialized world work tirelessly to comply with cGMP requirements to produce in compliant facilities, industries in the developing…
product, and it does not have to be done in a long, arduous process. With this in mind, quality risk management can and should be integrated into the daily operations ... management provides a detailed information for…
manufacturing without complicating the engineering solutions Recommendations: it has become clear that in the pharmaceutical sector, an adequate risk management system is not only required by regulatory stakeholders…
other regions such as West Africa and the Southern African Development Community. Removing bottlenecks and reducing redundancies in regulatory processes that slow access to medicines for patients in need today…
expanding. Immunization is a key component behind the efforts taken to meet the Millennium Development Goals, particularly goal 4, which is reducing the child mortality rates. For the first time ... approaches can also…